Huons Meditech showcases key products at FIME 2024

Huons Meditech said it participated in the Florida International Medical Expo (FIME) 2024, the largest medical device exhibition in the U.S., held in Florida from June 19-21.

At the event, Huons Meditech unveiled the ASADAL-M1 lithotripter, designed for the fragmentation of kidney stones, and the Huen Single endoscope washer/disinfector in the CSSD segment. In the aesthetic category, the company promoted the DermaShine Pro, a mesotherapy injector utilizing negative pressure. 

The ASADAL-M1, certified by the U.S. FDA and the European Medical Device Regulation (CE), employs electro-magnetic extracorporeal shockwave (ESWL) technology to ensure safe and efficient lithotripsy. The non-invasive ESWL procedure, in contrast to traditional surgical stone removal, boasts a quick procedure time and allows for same-day treatment and discharge.

The Huen Single is an automatic endoscope washer/disinfector using a single-use peracetic acid (PAA) disinfectant solution, Sco-Single. It inhibits biofilm formation on both internal and external surfaces of endoscopes and sterilizes all pathogenic microorganisms, including spores, within five minutes. Unlike many endoscope disinfectors that reuse disinfectant solutions, increasing the risk of cross-contamination, the Huen Single uses a single-use disinfectant, eliminating the risk. It also features Clean-in-Place (CIP) functionality and a photocatalytic filter that purifies peracetic acid gases and odors, enhancing device durability and user safety, which attracted high interest from attendees.

The DermaShine Pro, the latest model in the highly successful DermaShine series, features an upgraded pressure-sensing injection system that allows for precise drug infusion and speed settings. Compatible with various syringes (32G, 34G, and 9-pin sterile needles), the device is expected for U.S FDA approval by the second half of next year, leading to numerous inquiries from attendees.

Lee Jin-suk, CEO of Huons Meditech, said the company was strengthening partnerships to expand into global markets through participation in major exhibitions,.

"We will continue to introduce our innovative medical devices, developed with proprietary technology, at exhibitions to increase buyer interest and strive to establish ourselves as a leading global medical device company."